Collagen XXIII is a transmembrane collagen previously shown to be upregulated in metastatic prostate cancer that has been used as a tissue and fluid biomarker for nonsmall cell lung cancer and prostate cancer. To determine whether collagen XXIII facilitates cancer cell metastasis in vivo and to establish a function for collagen XXIII in cancer progression, collagen XXIII knockdown cells were examined for alterations in in vivo metastasis as well as in vitro cell adhesion. In experimental and spontaneous xenograft models of metastasis, H460 cells expressing collagen XXIII shRNA formed fewer lung metastases than control cells. Loss of collagen XXIII in H460 cells also impaired cell adhesion, anchorage-independent growth and cell seeding to the lung, but did not affect cell proliferation. Corroborating a role for collagen XXIII in cell adhesion, overexpression of collagen XXIII in H1299 cells, which do not express endogenous collagen XXIII, enhanced cell adhesion. Consequent reduction in OB-cadherin, alphacatenin, gamma-catenin, beta-catenin, vimentin and galectin-3 protein expression was also observed in response to loss of collagen XXIII. This study suggests a potential role for collagen XXIII in mediating metastasis by facilitating cell-cell and cell-matrix adhesion as well as anchorageindependent cell growth.
Introduction
The role of the tumor microenvironment is increasingly understood to be critical in promoting tumor growth, survival and dissemination (Whiteside, 2008; Joyce and Pollard, 2009 ). Stromal components, including fibroblasts, inflammatory cells and blood vessels contribute to this microenvironment along with extracellular matrix elements such as laminin, fibronectin and a variety of collagens. Although many studies have focused on the role of collagens that are secreted into the tumor extracellular matrix, transmembrane collagens, such as collagens XIII, XVII, XXIII and XXV, have been infrequently studied for their role in promoting tumor growth, invasion and metastasis.
Collagen XXIII is a member of the membraneassociated collagens with interrupted triple-helices family (Franzke et al., 2005) . It is structurally similar to collagen XIII and XXV-each with four noncollagenous and three collagenous domains, a short intracellular region with no known signaling capability, and a juxtamembranous furin-cleavage site (Pihlajaniemi and Tamminen, 1990; Hashimoto et al., 2002; Banyard et al., 2003; Vaisanen et al., 2004) . Collagen XVII, another membrane-associated collagen with interrupted triple-helices, has an extended intracellular domain, an ectodomain with 16 non-collagenous and 15 collagenous domains, and is cleaved by members of the A Disintegrin And Metalloproteinase family (Franzke et al., 2002 (Franzke et al., , 2004 (Franzke et al., , 2009 .
Alterations in transmembrane collagens-genetic mutations, abnormal processing or overexpressionare directly associated with disease, demonstrating the importance of transmembrane collagen function. In Alzheimer's-diseased tissue, the collagen XXV ectodomain binds to amyloid beta peptides within amyloid plaques (Hashimoto et al., 2002) , and its ability to regulate amyloid fibril formation in vitro has been demonstrated Osada et al., 2005; Soderberg et al., 2005) . Moreover, overexpression of collagen XXV in mice contributes to Alzheimer's pathogenesis (Tong et al., 2010) , and a genetic association between collagen XXV and Alzheimer's disease has also been reported (Forsell et al., 2010) .
Collagen XXIII expression is enriched in the highly metastatic rat prostate carcinoma cell line, AT6.1, as compared with sublines with lower metastatic potential (Banyard et al., 2003) . Furthermore, using patient samples, collagen XXIII was experimentally validated as a biomarker for non-small cell lung cancer (NSCLC) detection and recurrence (Spivey et al., 2010) , and prostate cancer recurrence (Banyard et al., 2007) . These strong correlations prompted our exploration of collagen XXIII function in cancer metastasis.
Potential functions for collagen XXIII may be inferred from studies on other transmembrane collagens. Membraneassociated collagen XIII, for example, has been implicated in mediating muscle fiber attachment to the underlying basement membrane. Transgenic mice expressing altered collagen XIII lacking the cytoplasmic and transmembrane domains exhibit myopathy, and fibroblasts derived from these same mice exhibit impaired adhesion to collagen IV in vitro relative to fibroblasts expressing the membrane-associated form (Kvist et al., 2001) . Blocking collagen XIII-collagen IV interactions with soluble collagen XIII ectodomain also results in decreased fibroblast adhesion (Vaisanen et al., 2004 (Vaisanen et al., , 2005 . Corneal epithelial cells, which express endogenous cell surface collagen XXIII, also exhibit impaired adhesion to collagen IV in the presence of soluble collagen XXIII (Gordon et al., 2005) .
Using a genetic approach to manipulate collagen XXIII levels in human and rat carcinoma cell lines, we investigated the role of collagen XXIII in cancer cell metastasis in both spontaneous and experimental models of metastasis, in vivo. We further investigated whether collagen XXIII has a functional role in mediating cell morphology, cell-cell and cell-matrix adhesion, or anchorage-independent growth. Our results suggest that collagen XXIII mediates both heterotypic and homotypic cell adhesion. In light of these results, we examined the effects of collagen XXIII knockdown in vitro on the expression of proteins with known roles in cell morphology or adhesion-including OB-cadherin, a-, b-and g-catenin, vimentin, galectin-3 and members of the integrin family. In summary, our findings suggest that collagen XXIII contributes to successful cancer cell metastasis in part through its function in cell adhesion, and that changes in collagen XXIII expression affect other proteins with structural and adhesive roles.
Results

Generation of stable cell lines
Collagen XXIII was originally identified in the highly metastatic rat Dunning prostate carcinoma cell line AT6.1 in a screen for potential mediators of prostate cancer metastasis (Banyard et al., 2003) . To determine whether collagen XXIII has a necessary role in tumorigenesis and metastasis, cell lines stably expressing shorthairpin RNAs (shRNA) or micro RNAs (miRNA) were employed. Clonal H460 cell lines stably expressing the pRS vector, encoding no shRNA (pRS) or shRNA against green fluorescent protein (GFP) (shGFP) were compared with H460 cell lines stably expressing one of two unique shRNA sequences targeting the coding sequence of collagen XXIII (sh#57 and sh#58) (Supplementary Figure 1A ). For a subset of experiments, additional cell lines were used in parallel: AT6.1 parental and clonal AT6.1 cell lines that stably express pcDNA6.2 control or collagen XXIII-specific miRNA; H1299 cells expressing control shRNA or collagen XXIII shRNA. H1299 cells expressing control pcDNA-DEST40 or overexpressing collagen XXIII as well as H460 sh#57 and sh#58 cells with rescued collagen XXIII expression were used as additional controls (Supplementary Figures 1B-D) .
Loss of collagen XXIII: effects on experimental and spontaneous mouse models of metastasis In two in vivo models of metastasis, metastasis formation in the lung was enhanced in mice injected with control cells expressing high (pRS) levels of collagen XXIII compared with mice injected with collagen XXIIIknockdown cells (sh#57 or sh#58). In the spontaneous metastasis model, where lung metastasis is assessed 3 weeks after primary tumor resection, mice in the control group had an average of 7.9 lung nodules as compared with 0.6 and 1.3 in the knockdown groups (one-way analysis of variance (ANOVA), Po0.001) (Figure 1a ). For the metastasis experiments, mice with tumors greater than 1 cm 3 were not included in the analysis. Therefore, differences in tumor size were not responsible for the reduction in metastasis observed in the knockdown group, as the average primary tumor Figure 1 Loss of collagen XXIII inhibits spontaneous and experimental H460 cell metastasis and cell retention in the lung. (a) Female severe combined immunodeficiency mice were inoculated subcutaneously with 2 Â 10 6 control (pRS) or collagen XXIII knockdown (sh#57 and sh#58) cells into the right flank. Tumors were aseptically resected after 3 weeks and the lungs were collected 3 weeks post-resection. The number of mice per group is indicated in parentheses, as mice were only included in the analysis if their tumor volume was between 100 and 1000 mm 3 . Box and whiskers plot (Tukey) indicates the average number of lung metastases per mouse in each group (one-way ANOVA, Po0.001). (b) Female severe combined immunodeficiency mice were inoculated intravenously with 1 Â 10 6 H460 pRS or sh#58 cells. After 40 days, lungs were collected and analyzed for metastases. Box and whiskers plot (Tukey) designates the average number of experimental lung metastases per mouse in each group (t-test, *Po0.01). (c) Nude mice were inoculated intravenously with 2.5 Â 10 6 5-chloromethylfluorescein diacetate-labeled control (pRS) or knockdown (sh#58) H460 cells. After 5 h, lungs were perfused and digested mechanically and enzymatically. The proportion of labeled tumor cells within 5 Â 10 5 total cells was determined for each mouse using the FACSCalibur system (t-test; *P ¼ 0.01).
volume was similar between the groups (Supplementary Figure 2a) . Endogenous collagen XXIII expression in control tumors was confirmed by immunohistochemistry ( Supplementary Figures 2B and C) . A similar result was observed in a subsequent spontaneous metastasis experiment (Supplementary Figure 3A) . These observations were validated in an experimental model of metastasis, which employs tail vein inoculation and recapitulates the later stages of metastasis, after the cells have exited the primary site and entered into the blood stream. Control group mice had on average more metastatic lung nodules than mice in the collagen XXIII knockdown group, with a mean of 28.75 and 0.833 lung nodules, respectively (t-test, Po0.01) (Figure 1b) .
Loss of collagen XXIII: effects on cell retention in the mouse lung after hematogenous dissemination In an attempt to understand whether collagen XXIII enhances cancer cell retention in the lung after hematogenous metastasis in vivo, the number of H460 control and knockdown cells present in the lung at early time points after intravenous inoculation was determined. The relative proportion of adherent H460 pRS or sh#58 5-chloromethylfluorescein diacetate-labeled tumor cells was assessed using flow cytometry. H460 pRS cells were present in the lungs at higher proportions than the H460 sh#58 cells, representing 0.21 and 0.07% of the total lung cell population, respectively (t-test; P ¼ 0.01) (Figure 1c) . A similar trend was seen when comparing the H460 pRS and sh#57 cell lines in a separate experiment (Supplementary Figure 3B) .
Detection of collagen XXIII on the surface of H460 cells Collagen XXIII localization in H460 cells could provide insight into its function as a potential mediator of metastasis. Collagen XXIII is a transmembrane protein that primarily localizes to the Golgi apparatus and the plasma membrane (Veit et al., 2007) . Using immunofluorescence, we examined the cellular localization of endogenous collagen XXIII in H460 cells. In unpermeabilized H460 pRS cells, cell surface collagen XXIII was found at sites of cell-cell contacts (Supplementary Figure 4A) , whereas intracellular gamma-catenin was not detected (Supplementary Figure 4B) . When cells were not engaged in cell-cell contacts, especially when seeded at low densities, a more diffuse pattern of cell surface staining was observed. These results suggest that cell surface collagen XXIII is enriched at sites of cell-cell contacts. Intracellular collagen XXIII was detected in the Golgi apparatus (Supplementary Figure 4C ) and gamma-catenin was also detected at sites of cell-cell contacts (Supplementary Figure 4D) .
Loss of collagen XXIII: effects on cell proliferation
Certain proteins regulate cell proliferation and loss of these proteins can alter a cell's ability to form macroscopic metastasis, in vivo. To examine whether collagen XXIII affects cell proliferation in vitro, stable cell lines were seeded in 96-well plates and allowed to grow in the presence of serum for 24, 48, 72 or 96 h followed by fluorescent cell labeling. Comparison of relative fluorescent units (RFUs) at each time point revealed highly similar RFUs, indicating that collagen XXIII does not provide a growth advantage for cells in vitro (Figure 2a ).
Loss of collagen XXIII: effects on anchorage-independent growth Cancer cells are characterized by anchorage-independence-an ability to survive and proliferate in the absence of a two-dimensional adhesive substrate. Analysis of colony formation efficiency of H460 control or knockdown cell suspensions, revealed a role for collagen XXIII in anchorage-independent cell growth. Control cells formed significantly more colonies in soft agar than the knockdown cells. Specifically, of the 500 cells initially seeded in agar, a mean of 253 pRS, 247 shGFP, 61 sh#57 and 93 sh#58 cells formed detectable colonies within 2 weeks with plating efficiency values of 51, 49, 12 and 19%, respectively (mixed model ANOVA; Po0.001) (Figure 2b ).
Altered collagen XXIII protein expression affects cell morphology
Cell surface expression of collagen XXIII may influence H460 cell shape. To assess whether silencing collagen XXIII influences H460 cell morphology, phase-contrast microscopy was used to analyze changes in cell shape between stable control and knockdown H460 cell lines. In cell lines with high collagen XXIII levels, individual cells appear spread-characterized by cellular protrusions and cell-substratum attachments-especially at early time points after seeding. Knockdown cells, in contrast, appear more rounded with less surface area and fewer attachment sites (Figures 3a-d) . Specifically, the average surface area (measured in pixels) of the control cells (pRS, 4717; shGFP, 3859) was significantly larger than that of the knockdown cells (sh#57, 2186; sh#58, 2305) (Figure 3g ; mixed model ANOVA, Po0.001). Morphological differences were not observed in H1299 cells, which do not express endogenous collagen XXIII, that stably express control or collagen XXIII shRNA (Figures 3f and e) . Moreover, in the presence of trypsin or non-enzymatic cell-lifting solutions, H460 knockdown cell lines detached from tissueculture-treated plates earlier than control cells, presumably due to their decreased adhesive capability.
Loss of collagen XXIII: effects on cell aggregation in suspension Cell adhesion molecules (CAMs) can also facilitate homotypic cellular interactions. In an effort to examine collagen XXIII's contribution to cell aggregation in suspension, H460 stable cell lines were grown for 24 h in Costar ultra-low attachment plates (Corning Life Sciences, Lowell, MA, USA). Microscopic analysis revealed differences in cell aggregate size and shape when comparing the control and collagen XXIII knockdown H460 cell lines (Figures 4a-d) , but not the H1299 control and knockdown cell lines, which do not express endogenous collagen XXIII (Figures 4e and f) . Specifically, control H460 cells formed large and tightly aggregated clumps, whereas H460 knockdown cell lines formed more loosely dispersed aggregates. Stable overexpression of human collagen XXIII in H1299 cells led to an increase in aggregate size (Po0.001) (Figure 4g ), supporting the hypothesis that collagen XXIII aids homotypic cell adhesion.
Loss of collagen XXIII: effects on cell adhesion to extracellular matrix molecules The role of collagen XXIII in cell-matrix adhesion was examined by analyzing H460 parental, control and knockdown cell line adhesion to tissue-culture-treated plates coated with different matrix molecules. Significant differences in cell adhesion on all matrices were observed when comparing the mean number of attached control and knockdown cells (Figures 5a-e and Supplementary Table 1 ). The results suggest a link between collagen XXIII protein level and adhesive ability to many different matrices.
Tissue-culture-treated plates promote non-specific cell adhesion. In an attempt to identify preferred matrix ligands, the cell adhesion experiments were repeated on non-tissue-culture-treated plates coated with matrix protein and blocked with albumin. In agreement with our previous cell adhesion data, the knockdown cell lines were less adherent to nearly all matrix molecules examined as compared with the control cell lines (Supplementary  Figure 5A-E and Supplementary Table 2) . Similar results were also seen when comparing AT6.1 cell lines stably expressing control (GC2_6 and GC2_9) or collagen XXIII (1610_1 and 1610_2) miRNA (mixed model ANOVA; Po0.001) (Figure 5f ). To ensure that these effects were not due to off-target effects of the shRNA, control (pRS) or collagen XXIII (sh#57 or sh#58) shRNA constructs were stably expressed in H1299 cells, which lack detectable collagen XXIII. H1299 control and knockdown cells similarly adhered to collagen IV (Figure 5g ), indicating that these shRNAs do not alter cell adhesion independently of collagen XXIII. In contrast, H1299 cells overexpressing collagen XXIII exhibit increased adhesive capability (Supplementary Figure 5F and Supplementary Table 3) . Moreover, rescue of collagen XXIII expression in the H460 sh#57 and sh#58 cell lines also improved cell adhesion on collagen IV (Supplementary Figure 5G  and Supplementary Table 3) . These results reveal a clear correlation between collagen XXIII expression and cell adhesion to a variety of extracellular matrix components.
Loss of collagen XXIII: effects on cell adhesion to endothelial cell monolayers To examine whether collagen XXIII is also involved in heterotypic cell interactions, we measured H460 clonal cell adhesion to human umbilical vein endothelial cell (HUVEC) monolayers. Of the cells initially seeded on HUVEC monolayers, 51% (pRS) or 52% (shGFP) of the control cells and 31% (sh#57) or 30% (sh#58) of the knockdown cells were able to adhere to the monolayers within 40 min (mixed model ANOVA; Po0.001) (Figure 5h ). Similar results were obtained when measuring H460 cell adhesion to human microvascular endothelial cells (Figure 5i ). Microscopic examination of the cocultured cells revealed H460 interactions both with the HUVECs and human microvascular endothelial cells and the exposed matrix deposited by the HUVECsindicating that collagen XXIII mediates heterotypic cell interactions as well as cell-matrix interactions.
Loss of collagen XXIII: effects on protein expression Stable repression of collagen XXIII resulted in cell rounding and decreased adhesive ability. Therefore, western blot analysis was used to examine changes in other proteins with known roles in cell adhesion and structure. Our data show that stable knockdown of collagen XXIII does not lead to reduced protein expression of integrin aV, a2, a5 or b1 nor with the expression of focal adhesion kinase, Src or ILK1, which can be modulated by integrins. Interestingly, one of the collagen XXIII knockdown clones showed a substantial reduction in integrin a6 expression (Supplementary Figure 6 ). More strikingly, stable repression of collagen XXIII led to decreased protein expression of cell adhesion complex proteins including OB-cadherin, b-catenin, a-catenin and g-catenin as well as vimentin and galectin-3 ( Figure 6 ). E-cadherin and N-cadherin levels were undetectable in the control and knockdown cell lysates as revealed by western blot. Analysis of total RNA in the control and knockdown cells revealed a reduction in OB-cadherin RNA levels, but not a-, b-, dand g-catenin (Supplementary Figure 7A) . Furthermore, treatment of the knockdown cell lines with the proteasome inhibitors MG115 and MG132 stabilized b-and g-catenin protein levels (Supplementary Figure 7B) . This indicates that collagen XXIII may regulate the Figure 4 Loss of collagen XXIII affects H460 cell aggregation in suspension. H460 (a) pRS, (b) shGFP, (c) sh#57 or (d) sh#58 cells were seeded into plates coated with an ultra-low attachment surface (Corning Life Sciences) and cell aggregate density was visualized using light microscopy. Representative phase-contrast micrographs depict differences in cell aggregation density between (a, b) collagen XXIII-expressing cells and (c, d) collagen XXIII knockdown cells. Representative phase-contrast micrographs of aggregated H1299 (e) pRS and (f) sh#58 cells, which lack endogenous collagen XXIII, indicate similar aggregation densities 24 h after seeding. (g) In contrast, overexpression of collagen XXIII in H1299 cells (DEST40c23) resulted in larger cell aggregates than the control cell line (DEST40). Aggregate size was quantified by fluorescently labeling the aggregates 5 h after seeding and determining the number of pixels per aggregate using Image J software (mixed model ANOVA; *Po0.001). Three or more independent experiments were performed in triplicate for each cell line. expression or stability of certain CAMs, thereby influencing the overall adhesive capacity of the cells.
Discussion
Metastasis is responsible for the majority of cancerrelated deaths each year, and much effort has focused on identifying the underlying genetic and proteomic alterations that drive this process. In this study, we demonstrate a correlation between collagen XXIII and increased lung metastasis in two in vivo models of metastasis-indicating that collagen XXIII enhances the metastatic potential of these cells. Mediators of metastasis can exhibit a broad spectrum of functionalities including adhesion, migration, proliferation and survival. CAMs are important mediators of cell-cell and cell-matrix adhesion. Certain CAMs, including members of the integrin family such as a1b1, a2b1 and avb3, can interact with multiple matrix molecules (Barczyk et al., 2010) . Many CAMs exhibit altered protein expression in cancer cells and have known roles in metastasis (Schmidmaier and Baumann, 2008) . For example, in vivo metastasis of lung carcinoma cells is reduced by antibody-blocking of b1 integrin (Takenaka et al., 2000) as well as RNAi-mediated knockdown of a5b1 integrin (Roman et al., 2010) . Relatedly, trans- Figure 5 Loss of collagen XXIII affects cell adhesion. H460 parental (white) and H460 cells stably expressing control (pRS and shGFP; black and gray) or COL23A1 (sh#57 and sh#58; diagonal and horizontal stripes) shRNA were seeded in triplicate on tissueculture-treated 96-well plates coated with 5 mg/cm 2 of (a) collagen I, (b) collagen IV, (c) fibronectin, (d) laminin or (e) 1 mg/cm 2 vitronectin and allowed to adhere for 1 h. (f) AT6.1 parental (white) cells and AT6.1 cells stably expressing control (GC2_6 and GC2_9; black and gray) or COL23A1 (1610_1 and 1610_2; diagonal and vertical stripes) miRNA and (g) H1299 cells (which do not express detectable endogenous collagen XXIII) stably expressing control (pRS; black) or collagen XXIII shRNA (sh#57 and sh#58; diagonal and horizontal stripes) were seeded in plates coated with 5 mg/cm 2 of collagen IV. For the cell-matrix adhesion experiments, unattached cells were removed with PBS and fluorescent cell labeling was used to determine the relative number of attached cells per well. Bars indicate the average proportion of adhered cells (after normalization to the parental or control cell line) ± s.e.m. Shown are the mean of three or more independent experiments performed in triplicate. (h) H460 control and knockdown cell lines were seeded onto HUVEC monolayers and allowed to adhere for 40 min. The number of adhered tumor cells was determined by comparing the total number of cells in wells containing either HUVECs alone or HUVECs and tumor cells. Shown are the mean±s.e.m. of three independent experiments, each performed in triplicate. For all experiments, asterisks indicate a significant difference (*Po0.001) between the means of the control and knockdown cell lines as determined using mixed model ANOVA. (i) H460 control and knockdown cell lines were seeded onto human microvascular endothelial cell monolayers as described for HUVEC. Shown are the mean number of adhered fluorescently labeled tumor cells from four data points ± s.d. Cell number converted from a standard curve of labeled cells. Representative data shown from more than four independent experiments. For all experiments, asterisks indicate a significant difference (*Po0.001) between the means of the control and knockdown cell lines as determined using mixed model ANOVA. membrane collagens are known CAMs, present in hemidesmosomes (collagen XVII) or focal adhesions (collagen XIII), and have diverse binding partners (Diaz et al., 1990; Hagg et al., 2001; Tu et al., 2002; Franzke et al., 2003 Franzke et al., , 2005 Veit et al., 2007) . Collagen XXIII has recently been shown to bind a2b1 integrin in keratinocytes (Veit et al., 2011) and aids corneal epithelial cell binding to collagen IV and Matrigel (BD Biosciences, Bedford, MA, USA) (Gordon et al., 2005) .
Manipulation of collagen XXIII protein levels in cancer cell lines allowed us to determine whether collagen XXIII is necessary for different cellular functions and behaviors. Our results suggest that loss of collagen XXIII may globally impair cell adhesionincluding cell-matrix adhesion, homotypic and heterotypic cell adhesion-and diminishes cancer cell retention in the lung after hematogenous dissemination. These data make it possible to articulate more than one model for collagen XXIII function in metastasis. Collagen XXIII may facilitate cancer cell metastasis by mediating initial adhesion to the endothelium or exposed extracellular matrix, by promoting cancer cell aggregation within the blood vessels or a combination of both. Similar functionalities have been observed with other proteins and are associated with increased metastasis formation. Increased galectin-3 and Thomsen-Friendenreich antigen expression, for example, correlate with metastatic potential and aid tumor cell adhesion to the endothelium (Khaldoyanidi et al., 2003) . These proteins also enhance homotypic cancer cell adhesion following initial heterotypic adhesion to the endothelium Khaldoyanidi et al., 2003) .
Anchorage-independent growth is a defining feature of cancer cells and correlates with metastatic potential (Cifone and Fidler, 1980; Nomura et al., 1989) . CAMs can facilitate this process. Collagen XXIII expression is positively correlated with anchorage-independent growth of H460 cells. Changes in colony size and cell proliferation on tissue culture plates were not readily apparent; suggesting that collagen XXIII enhances colony formation efficiency without endowing cells with a proliferative advantage. Therefore, collagen XXIII may facilitate cell growth and survival when cancer cells are rounded and incapable of spreading. This property could be especially important when metastasizing cells reside temporarily within the blood vessels.
Stable repression or overexpression of an individual protein can trigger additional proteomic changes within the cell. In some cases, these secondary changes are partially responsible for phenotypic and behavioral differences between clonal cell lines. Examination of proteomic changes in response to collagen XXIII knockdown revealed decreased protein expression of OB-cadherin, b-catenin, a-catenin and g-catenin, vimentin, galectin-3 and potentially a-6 integrin-each of which can affect cell morphology and adhesion.
H460 cells express high levels of OB-cadherin, which is normally expressed in osteoblasts and mesenchymal cells (Okazaki et al., 1994; Simonneau et al., 1995) and misexpressed in metastatic breast and prostate cancer cells (Pishvaian et al., 1999; Bussemakers et al., 2000; Tomita et al., 2000; Chu et al., 2008) . OB-cadherin interacts with other cadherin molecules at the cell surface to form adherens junctions at sites of cell-cell contact, while the intracellular tail of OB-cadherin interacts with members of the catenin family (Pishvaian et al., 1999) . Though the link between collagen XXIII and OBcadherin remains incompletely understood, others have shown that reducing OB-cadherin expression disrupts bcatenin and g-catenin abundance (Di Benedetto et al., 2010) ; potentially explaining why we observe a reduction in both OB-cadherin and catenin protein levels but only OB-cadherin RNA levels. A reduction in a6 integrin could also affect the adhesive and metastatic ability of the H460 collagen XXIII knockdown cells, as a6 integrin is important for cell adhesion on laminin and high a6 levels correlate with the metastatic phenotype in breast cancer cells (Wewer et al., 1997; Mukhopadhyay et al., 1999; Torimura et al., 1999) . Expression of either galectin-3 (Khaldoyanidi et al., 2003) or the intermediate Figure 6 shRNA-mediated silencing of collagen XXIII alters the expression of proteins involved in cell adhesion and structure. Whole-cell lysates were collected from H460 clonal cell lines and probed for various proteins involved in cell adhesion. In the knockdown cell lines, a reduction in OB-cadherin, g-, b-and a-catenin, vimentin and galectin-3 was observed. Analysis of the canonical cadherins revealed no changes in P-cadherin. E-and N-cadherin are not expressed in these cells. Actin was used as a loading control. filament vimentin (Gilles et al., 1996; Hu et al., 2004) in carcinomas is also associated with metastasis.
Together, our results demonstrate a functional role for collagen XXIII in facilitating the formation of pulmonary metastases. This result is consistent with previous reports indicating that elevated collagen XXIII levels are associated with metastasis and with poor outcome in patients with prostate cancer and non-small cell carcinoma of the lung (Banyard et al., 2007; Spivey et al., 2010) . We further provide a potential mechanism in which expression of collagen XXIII by tumor cells facilitates heterotypic adhesion to endothelium-a known requirement for tumor cell extravasation into distal organs (Orr and Wang, 2001; Miles et al., 2008) . We also find that collagen XXIII mediates increased homotypic adhesion leading to increased cell aggregation, a phenomenon also reported to be associated with increased metastatic potential. These findings demonstrate that a transmembrane collagen can influence tumor metastasis in animals. Future studies will determine how this molecule could influence tumor aggressiveness and patient outcome in humans.
Materials and methods
Cell culture, transfection and immunoblot analysis
The H460 and H1299 (American Type Culture Collection) cells were cultured in recommended media and the AT6.1 cells (provided by J Isaacs, Johns Hopkins University) were maintained as previously described (Isaacs et al., 1986) . For the proteasome inhibition experiments, knockdown cells (sh#57 and sh#58) were treated with either dimethyl sulfoxide, carbobenzoxy-L-leucyl-L-leucyl-L-norvalinal (MG115), N-(benzyloxycarbonyl) leucinylleucinylleucinal (MG132) or N-acetylLeu-Leu-Nle-CHO (Sigma-Aldrich, St Louis, MO, USA) before lysate collection. Whole-cell lysates were collected using Triton Lysis Buffer or RIPA Buffer (Boston BioProducts, Ashland, MA, USA) and supplemented with complete mini protease inhibitor cocktail tablets (Roche Diagnostics, Indianapolis, IN, USA). Lysate protein concentration was determined using the BCA assay (Pierce Biotechnology, Rockford, IL, USA). Whole-cell lysates were resolved on Tris-HCl gels and transferred to a polyvinylidene difluoride membrane (Millipore, Billerica, MA, USA) and proteins were visualized using the Amersham ECL Plus chemiluminescence kit (GE Healthcare, Pittsburgh, PA, USA). The antibodies used were mouse monoclonal antibodies to collagen XXIII, galectin-3 (R&D Systems, Inc., Minneapolis, MN, USA), integrins a2, a3, a5, b3, b-catenin, p120-catenin, E-, N-and Pcadherin, focal adhesion kinase, pFAK397 (BD Biosciences), actin (Millipore), vimentin (DAKO, Carpinteria, CA, USA) and rabbit antibodies to ILK1, a-catenin, g-catenin, OBcadherin, AKT, Src, pSrcY416 and integrins a4, av, a6, b1, b4, b5 (Cell Signaling Technology, Danvers, MA, USA) .
Generation of stable cell lines
For knockdown studies, H460 or H1299 cells were transfected with an empty pRS vector, pRS encoding shRNA against collagen XXIII (sh#57 or sh#58) or pRS encoding ineffective shRNA against GFP (shGFP) (TR317712, Origene, Rockville, MD, USA) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). After selection in puromycin, clonal cell lines were established. Collagen XXIII expression was rescued by transfecting the sh#57 cell line with an empty pcDNA-DEST40 expression vector or pcDNA-DEST40COL23A1, or transfecting the sh#58 cell line with an empty pcDNA3 expression vector or pcDNA3-human collagen XXIIIR110A (mutated at the furin cleavage site) (Banyard et al., 2007) . Cells were pooled after selection in puromycin and Geneticin (Invitrogen). H1299 cells were separately transfected with an empty pcDNA-DEST40 expression vector or pcDNA-DEST40COL23A1, and pooled cells were collected after selection in Geneticin. To generate pcDNA-DEST40CO-L23A1, collagen XXIII was PCR amplified from pcDNA3-COL23A1 (Banyard et al., 2007) 
Statistical analysis
Mixed model ANOVA was used to assess significant changes in cell adhesion, aggregation or growth in soft agar between control and knockdown cell lines, taking account of random variation among replicate experiments. The mean of the knockdown cells was subtracted from the mean of the control cells and compared with zero. For each comparison, the P-value, if significant, is reported. One-way ANOVA followed by Bonferroni's post-test or a t-test were used to analyze the relationship between collagen XXIII status in H460 sublines and the number of spontaneous or experimental metastases formed in vivo as well as for experiments involving the H1299 cells. The analyses were performed by SPSS 15.0 for Windows (IBM Corporation, Armonk, NY, USA).
Proliferation assays
In all, 1 Â 10 4 cells were seeded into each well of a 96-well plate and allowed to grow for 24, 48, 72 or 96 h. CyQUANT reagent (Invitrogen) was used to fluorescently label cells. Average RFU were calculated for each set of replicates, and fold change in RFU at each time point relative to RFU at 24 h is reported.
Adhesion assays
Tissue-culture (tc)-treated plates (96 well) were coated with 5 mg/cm 2 human fibronectin, mouse laminin, mouse collagen IV (BD Biosciences), Cultrex bovine collagen I (Trevigen, Gaithersburg, MD, USA) or 1 mg/cm 2 human vitronectin (Millipore) for 1 h, diluted according to the manufacturer's recommendations. Adhesion assays were also repeated on nontc-treated plates coated with each matrix molecule and blocked with a bovine serum albumin solution for 1 h. Cells were detached using EDTA solution (0.15 g disodium EDTA, 4 g NaCl, 0.28 g sodium bicarbonate, 0.5 g dextrose and 0.2 g KCl dissolved in 500 ml water, sterile filtered), and 3 Â 10 4 cells were allowed to adhere in each well for 1 h at 37 1C in serum-free media. Plates were washed with phosphate-buffered saline (PBS) to remove any unattached cells and CyQUANT reagent was used to fluorescently label adherent cells. Cell lines were also seeded onto HUVEC or human microvascular endothelial cell monolayers and allowed to adhere for 40 min. The number of adhered tumor cells was determined by comparing the total number of cells in wells containing either endothelial cells alone or with tumor cells.
Soft agar assays
In all, 500 cells were suspended in 0.35% agar in complete RPMI and overlayed onto a 0.5% agar in RPMI base. Colony formation efficiency was calculated using the following equation: (# of visible colonies after 12 days)/(# of cells originally seeded).
Immunofluorescence H460 cells were seeded on collagen I-coated coverslips and incubated at 37 1C. Extensive Dulbecco's PBS washing was performed before fixation and between all subsequent steps unless otherwise noted. Cells were fixed using 1% paraformaldehyde for 2 min on ice followed by 10 min at room temperature. Unless cell surface staining was desired, cells were permeabilized using 0.5% Triton X-100/Dulbecco's PBS and blocked using 10% normal goat serum/Dulbecco's PBS with no subsequent Dulbecco's PBS wash. Following an hour of incubation with the collagen XXIII clone 468642 (R&D systems) or g-catenin (Cell Signal) antibodies at room temperature, the Alexa-488 or Alexa-568-conjugated secondary antibodies (Molecular Probes, Invitrogen) were added for 1 h. Cells were mounted in ProLong Gold Antifade Reagent (Invitrogen) and imaged using the appropriate filters. Cells were viewed using a Nikon Eclipse TE200 inverted light microscope (Nikon Instruments, Melville, NY, USA) and images were acquired using the SPOT Insight imaging system (Diagnostic Instruments, Inc., Sterling Heights, MI, USA).
Cell aggregation assays Adherent cells were detached using EDTA solution. Equal numbers of cells were plated into ultra-low attachment plates (Costar) and grown in suspension for 5-96 h. For the collagen XXIII overexpression cell lines, cell aggregates were labeled fluorescently using Calcein AM (Invitrogen) or CellTracker Green 5-chloromethylfluorescein diacetate (Invitrogen) according to the manufacturer's instructions. ImageJ software (NIH, Bethesda, MD, USA) analysis was used to determine the relative size (measured in pixels) of each aggregate (Rasband, 2010) .
PCR
Total RNA was isolated from the tissue culture cell lines using the RNeasy Plus kit (Qiagen, Valencia, CA, USA) and reversetranscribed using iScript (Bio-Rad Laboratories, Hercules, CA, USA). The resulting complementary DNA was amplified using TaKaRa Taq Polymerase (Clontech, Mountain View, CA, USA) and primers specific for OB-cadherin, collagen XXIII, b-catenin, d-catenin, a-catenin, g-catenin and GAPDH (Real Time Primers, Elkins Park, PA, USA). PCR products were visualized using gel electrophoresis.
Animal models
All animal experiments were performed under guidelines approved by the Children's Hospital Boston Animal Care and Use Committee and Animal Resources Committee. For a spontaneous model of metastasis, 2 Â 10 6 pRS or knockdown (sh#57 or sh#58) cells were injected subcutaneously into the right flank of 5-6-week-old female severe combined immunodeficiency mice. Caliper measurements of the subcutaneous tumors were taken thrice weekly and tumor volume (length Â width 2 ) was calculated. Subcutaneous tumors were aseptically resected 3 weeks after cell inoculation. After 3 additional weeks, mice were killed and the lungs were collected. Macroscopic surface metastases were counted followed by histological examination of serial lung sections. For all animal experiments, tissues were immediately fixed in 10% formalin.
For an experimental model of metastasis, 1 Â 10 6 control or knockdown H460 cells were injected intravenously into 6-week female severe combined immunodeficiency mice. After approximately 30 days, mice were killed and macroscopic lung metastases were counted before fixation in formalin. Paraffin-embedded serial lung sections were also histologically examined. To examine cancer cell adhesion to the lung at early time points, cell lines were fluorescently labeled with CellTracker Green 5-chloromethylfluorescein diacetate in vitro, according to the manufacturer's recommendation, and 2.5 Â 10 6 cells were intravenously injected into 5-6-week female nude (nu/nu) mice. After 5 h, animals were anesthetized and euthanized. The lungs were perfused with 3 ml PBS, mechanically digested and incubated in collagenase II solution (250 U/ml; Worthington Biochemical, Lakewood, NJ, USA). Cells were incubated with Red Blood Cell Lysis Reagent (Sigma), filtered through a 40-mm mesh filter and washed with Hanks' balanced salt solution between steps. The relative number of adhered cancer cells was determined using the FACSCalibur system. Gating was used to restrict analysis to 5 Â 10 5 single viable cells per mouse. The proportion of adherent tumor cells within the mouse lung was determined (# fluorescently labeled cells/5 Â 10 5 total cells).
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